|
EARS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.585530E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.334100E-02 |
| Normal-vs-Stage2 |
5.953400E-01 |
| Normal-vs-Stage3 |
2.138800E-03 |
| Normal-vs-Stage4 |
3.176700E-03 |
| Stage1-vs-Stage2 |
5.620700E-03 |
| Stage1-vs-Stage3 |
1.623990E-01 |
| Stage1-vs-Stage4 |
1.858810E-01 |
| Stage2-vs-Stage3 |
6.390500E-04 |
| Stage2-vs-Stage4 |
1.341120E-03 |
| Stage3-vs-Stage4 |
9.558000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.616500E-03 |
| Normal-vs-AfricanAmerican |
2.413400E-01 |
| Normal-vs-Asian |
2.246400E-02 |
| Caucasian-vs-AfricanAmerican |
4.512200E-01 |
| Caucasian-vs-Asian |
9.770400E-01 |
| AfricanAmerican-vs-Asian |
4.764200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.132360E-02 |
| Normal-vs-Female |
2.676000E-02 |
| Male-vs-Female |
3.680400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.635700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.110010E-02 |
| Normal-vs-Age(61-80Yrs) |
1.517360E-01 |
| Normal-vs-Age(81-100Yrs) |
2.139600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.457800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.537000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.388200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.904600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.159400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.418800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.560110E-02 |
| Classical-VS-Follicular |
1.799730E-03 |
| Classical-VS-Other |
3.084600E-01 |
| Classical-VS-Normal |
5.557700E-03 |
| Tall-VS-Follicular |
2.10819999999501E-05 |
| Tall-VS-Other |
8.848800E-01 |
| Tall-VS-Normal |
9.83230000000113E-05 |
| Follicular-VS-Other |
8.113700E-02 |
| Follicular-VS-Normal |
7.611600E-01 |
| Other-VS-Normal |
4.343700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.138760E-01 |
| Normal-vs-N1 |
3.67780000000151E-05 |
| N0-vs-N1 |
1.757240E-03 |
|
|
